Laboratories Consolidate Clinical Chemistry and Immunoassay Analyzers
By LabMedica International staff writers Posted on 09 Dec 2008 |
An open track-based system will enable laboratories to consolidate and automate sample processing procedures.
Laboratory automation provides more efficient sample management, improved laboratory services, and shortened turnaround times. The open track-based system offers medium to large-sized hospital and private laboratories flexibility and access to additional testing capabilities.
Olympus Life Science Europa (Hamburg, Germany) has signed an agreement with Thermo Fisher Scientific (Waltham, MA, USA) for open-track automation for clinical laboratories. The new product offering will complement existing Olympus Laboratory Automation products, including the OLA2500 peri-analytical automation system.
The agreement between the companies will allow laboratory professionals to consolidate Olympus AU-series clinical chemistry and immunoassay analyzers, including various third-party analyzers
Olympus will have the right to distribute Thermo Fisher's TC automation product line, a fully featured, track-based laboratory-automation product line, in the Americas.
Olympus will handle sales and marketing and will provide primary level service and support of the automation products.
By automating the main preanalytical steps, such as centrifugation, decapping, aliquoting and sorting, TC automation helps manage current and future workloads; it interfaces with Olympus systems plus a wide selection of third-party instruments.
Related Links:
Olympus Life Science Europa
Thermo Fisher Scientific
Laboratory automation provides more efficient sample management, improved laboratory services, and shortened turnaround times. The open track-based system offers medium to large-sized hospital and private laboratories flexibility and access to additional testing capabilities.
Olympus Life Science Europa (Hamburg, Germany) has signed an agreement with Thermo Fisher Scientific (Waltham, MA, USA) for open-track automation for clinical laboratories. The new product offering will complement existing Olympus Laboratory Automation products, including the OLA2500 peri-analytical automation system.
The agreement between the companies will allow laboratory professionals to consolidate Olympus AU-series clinical chemistry and immunoassay analyzers, including various third-party analyzers
Olympus will have the right to distribute Thermo Fisher's TC automation product line, a fully featured, track-based laboratory-automation product line, in the Americas.
Olympus will handle sales and marketing and will provide primary level service and support of the automation products.
By automating the main preanalytical steps, such as centrifugation, decapping, aliquoting and sorting, TC automation helps manage current and future workloads; it interfaces with Olympus systems plus a wide selection of third-party instruments.
Related Links:
Olympus Life Science Europa
Thermo Fisher Scientific
Latest Clinical Chem. News
- Paper Strip Saliva Test Detects Elevated Uric Acid Levels Without Blood Draws
- Prostate Cancer Markers Based on Chemical Make-Up of Calcifications to Speed Up Detection
- Breath Test Could Help Detect Blood Cancers
- ML-Powered Gas Sensors to Detect Pathogens and AMR at POC
- Saliva-Based Cancer Detection Technology Eliminates Need for Complex Sample Preparation
- Skin Swabs Could Detect Parkinson’s Years Before Symptoms Appear
- New Clinical Chemistry Analyzer Designed to Meet Growing Demands of Modern Labs
- New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results
- Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin
- Simple Urine Test Could Detect Multiple Cancers at Early Stage
- Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules
- First-Of-Its-Kind Quantitative Method Assesses Opioid Exposure in Newborns
- Paper-Based Devices Outperform Existing Methods in Diagnosing Asymptomatic Malaria
- Simple Skin Test Could Revolutionize Diagnosis of Pediatric Eosinophilic Esophagitis
- Portable Diagnostic Tool Uses Bioluminescence to Detect Viruses at POC
- AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress
Channels
Molecular Diagnostics
view channel
MRD Testing Can Identify Breast Cancer Survivors at Higher Risk of Recurrence
Breast cancer survival rates continue to improve, but recurrence remains incurable and affects around 30% of patients. Some subtypes, like triple negative and HER2+, relapse within years, while ER+ cancers... Read more
Cytoskeletal Protein Linked to Cervical Cancer Growth Paves Way for Precise Diagnostic Tools
Cervical cancer is the fourth most common cancer among women worldwide, with most cases caused by high-risk strains of human papillomavirus (HPV16 and HPV18). Despite improvements in surgery, radiation,... Read more
Molecular Allergy Chip Detects Allergic Asthma in Individual Patients
Asthma affects about 300 million people worldwide and is one of the most burdensome chronic lung diseases. Despite medical advances, most patients still receive uniform treatments such as corticosteroids,... Read more
Non-Invasive and Radiation-Free Diagnostic Identifies Early-Stage Lung Cancer Across All Subtypes
Lung cancer remains the leading cause of cancer-related deaths, with nearly 125,000 deaths and 227,000 new cases estimated in the U.S. for 2025. Despite evidence showing that early detection significantly... Read moreHematology
view channel
Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments
Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more
Platelets Could Improve Early and Minimally Invasive Detection of Cancer
Platelets are widely recognized for their role in blood clotting and scab formation, but they also play a crucial role in immune defense by detecting pathogens and recruiting immune cells.... Read more
Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment
Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read moreImmunology
view channel
Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Simple Genetic Testing Could Predict Treatment Success in Multiple Sclerosis Patients
Multiple sclerosis (MS) patients starting therapy often face a choice between interferon beta and glatiramer acetate, two equally established and well-tolerated first-line treatments. Until now, the decision... Read more
Novel Gene Signature Predicts Immunotherapy Response in Advanced Kidney Cancers
Sarcomatoid renal cell carcinoma (sRCC) is a rare, aggressive form of kidney cancer comprising about 5% of cases and is typically diagnosed at late stages. Resistant to most therapies, it has shown unusually... Read more
New Technology Deciphers Immune Cell Communication to Predict Immunotherapy Response
A healthy immune system depends on complex communication between specialized cell types that detect, alert, and eliminate harmful threats. When these immune signaling pathways break down, the result can... Read moreMicrobiology
view channel
New Diagnostic Method Confirms Sepsis Infections Earlier
Sepsis remains one of the most dangerous medical emergencies, often progressing rapidly and becoming fatal without timely intervention. Each hour of delayed treatment in septic shock reduces patient survival... Read more
New Markers Could Predict Risk of Severe Chlamydia Infection
Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Portable Spectroscopy Rapidly and Noninvasively Detects Bacterial Species in Vaginal Fluid
Vaginal health depends on maintaining a balanced microbiome, particularly certain Lactobacillus species. Disruption of this balance, known as dysbiosis, can increase risks of infection, pregnancy complications,... Read morePathology
view channel
New Method Enables Precise Detection of Nanoplastics in Body
Nanoplastic particles, with diameters under 0.001 millimeters, can penetrate body tissue and accumulate in organs. Because they are difficult to detect precisely, research into the health impacts of microplastics... Read more
AI-Powered Tool Improves Cancer Tissue Analysis
Cancer tissue analysis remains a critical step in tailoring treatments, yet current methods rely heavily on manual inspection of stained slides under a microscope. This process is labor-intensive, time-consuming,... Read more
AI Platform Uses 3D Visualization to Reveal Disease Biomarkers in Multiomics Data
The ability to visualize health data in three dimensions can reveal patterns and relationships among predictive biomarkers that conventional methods cannot. Biomarkers play a critical role in early diagnosis... Read moreTechnology
view channel
Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes
About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Wireless Sweat Patch Could Be Used as Diagnostic Test for Cystic Fibrosis
Cystic fibrosis (CF) is a genetic disease that causes excessive mucus to accumulate in the lungs, impairs digestion, and can affect multiple organs. More than 40,000 children and adults in the U.... Read moreIndustry
view channel
Siemens Healthineers and Carna Health Partner to Advance Kidney Care Innovation
Chronic kidney disease (CKD) is a growing global health challenge, particularly for high-risk and underserved populations. Early detection and management are essential but often hindered by limited access... Read more
Tempus AI Acquires Digital Pathology Company Paige
Tempus AI (Chicago, IL, USA) has acquired Paige (New York, NY, USA), an artificial intelligence (AI) company specializing in digital pathology. The acquisition allows Tempus to grow its dataset, expand... Read more
Vircell Launches New Website for Molecular Control Products
Vircell, a Spanish company specializing in human infectious diseases, has launched a new website for its AMPLIRUN® molecular control products. The site is designed to offer laboratories and professionals... Read more